Form 8-K - Current report:
SEC Accession No. 0001144204-15-057373
Filing Date
2015-09-30
Accepted
2015-09-30 13:58:08
Documents
8
Period of Report
2015-09-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT v421304_8k.htm 8-K 30960
2 EXHIBIT 1.1 v421304_ex1-1.htm EX-1.1 92012
3 EXHIBIT 4.1 v421304_ex4-1.htm EX-4.1 85434
4 EXHIBIT 4.2 v421304_ex4-2.htm EX-4.2 103758
5 EXHIBIT 5.1 v421304_ex5-1.htm EX-5.1 10797
6 EXHIBIT 10.1 v421304_ex10-1.htm EX-10.1 239456
7 EXHIBIT 10.2 v421304_ex10-2.htm EX-10.2 136940
8 GRAPHIC tlogo.jpg GRAPHIC 3815
  Complete submission text file 0001144204-15-057373.txt   706090
Mailing Address 3301 AGRICULTURE DRIVE MADISON WI 53716
Business Address 3301 AGRICULTURE DRIVE MADISON WI 53716 617-244-1616
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36598 | Film No.: 151133336
SIC: 2834 Pharmaceutical Preparations